BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15026414)

  • 1. Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models.
    Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Saito M; Kawagoe J; Takahashi K; Yada-Hashimoto N; Sakata M; Motoyama T; Kurachi H; Tasaka K; Murata Y
    J Biol Chem; 2004 May; 279(22):23477-85. PubMed ID: 15026414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
    Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Kawagoe J; Takahashi K; Yada-Hashimoto N; Seino-Noda H; Sakata M; Motoyama T; Kurachi H; Testa JR; Tasaka K; Murata Y
    Clin Cancer Res; 2004 Nov; 10(22):7645-54. PubMed ID: 15569997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.
    Kawaguchi H; Terai Y; Tanabe A; Sasaki H; Takai M; Fujiwara S; Ashihara K; Tanaka Y; Tanaka T; Tsunetoh S; Kanemura M; Ohmichi M
    J Ovarian Res; 2014 Apr; 7():38. PubMed ID: 24713296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers.
    Tsunetoh S; Terai Y; Sasaki H; Tanabe A; Tanaka Y; Sekijima T; Fujioka S; Kawaguchi H; Kanemura M; Yamashita Y; Ohmichi M
    Cancer Biol Ther; 2010 Dec; 10(11):1137-46. PubMed ID: 20935474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models.
    Ohta T; Ohmichi M; Hayasaka T; Mabuchi S; Saitoh M; Kawagoe J; Takahashi K; Igarashi H; Du B; Doshida M; Mirei IG; Motoyama T; Tasaka K; Kurachi H
    Endocrinology; 2006 Apr; 147(4):1761-9. PubMed ID: 16396982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
    Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
    Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gefitinib (ZD1839) increases the efficacy of cisplatin in ovarian cancer cells.
    Ohta T; Ohmichi M; Shibuya T; Takahashi T; Tsutsumi S; Takahashi K; Kurachi H
    Cancer Biol Ther; 2012 Apr; 13(6):408-16. PubMed ID: 22313686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
    Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
    Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
    Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS
    Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin.
    Arimoto-Ishida E; Ohmichi M; Mabuchi S; Takahashi T; Ohshima C; Hayakawa J; Kimura A; Takahashi K; Nishio Y; Sakata M; Kurachi H; Tasaka K; Murata Y
    Endocrinology; 2004 Apr; 145(4):2014-22. PubMed ID: 14701673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells.
    Kavandi L; Collier MA; Nguyen H; Syed V
    J Cell Biochem; 2012 Oct; 113(10):3143-52. PubMed ID: 22615136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory activity of nuclear factor-kappaB potentiates cisplatin-induced apoptosis in A549 cells.
    Zhang J; Xu Y; Xiong W; Zhang Z; Du C; Qiao L; Ni W; Chen S
    J Huazhong Univ Sci Technolog Med Sci; 2008 Jun; 28(3):251-6. PubMed ID: 18563317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
    Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Dec; 278(52):52598-612. PubMed ID: 14534291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels.
    Cohen-Lahav M; Shany S; Tobvin D; Chaimovitz C; Douvdevani A
    Nephrol Dial Transplant; 2006 Apr; 21(4):889-97. PubMed ID: 16455676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
    Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
    Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells.
    Zhong X; Li X; Wang G; Zhu Y; Hu G; Zhao J; Neace C; Ding H; Reed E; Li QQ
    Int J Oncol; 2004 Aug; 25(2):445-51. PubMed ID: 15254743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brown algae phlorotannins enhance the tumoricidal effect of cisplatin and ameliorate cisplatin nephrotoxicity.
    Yang YI; Ahn JH; Choi YS; Choi JH
    Gynecol Oncol; 2015 Feb; 136(2):355-64. PubMed ID: 25462204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.